1ml of DTT in liquid phase, in PET tube with capture cap, in bulk + sputum transfer device, for W...
FDA Device Recall #Z-0942-2026 — Class II — October 29, 2025
Recall Summary
| Recall Number | Z-0942-2026 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 29, 2025 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Copan Italia |
| Location | Brescia |
| Product Type | Devices |
| Quantity | 122,850 units US |
Product Description
1ml of DTT in liquid phase, in PET tube with capture cap, in bulk + sputum transfer device, for WASP* *Compatible with Copan s WASP (Walk-Away Specimen Processor for Microbiology) System
Reason for Recall
Treatment reagent functionality in respiratory specimens liquification cannot be guaranteed.
Distribution Pattern
US Distribution to states of: CA, CO, FL, GA, MN, MS, NH, NJ, NY, OH, PA, TN, TX, UT
Lot / Code Information
UDI:0U020N.A - (01)18053326005036
Other Recalls from Copan Italia
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0943-2026 | Class II | 1ml of DTT in liquid phase, in PET tube with ca... | Oct 29, 2025 |
| Z-1937-2025 | Class II | BD BBL CultureSwab EZ Collection and Transport ... | May 2, 2025 |
| Z-2440-2021 | Class II | COPAN FLOQSwabs, STERILE.EO, for drawing clini... | Jul 9, 2021 |
| Z-2131-2013 | Class III | WASP (Walk Away Specimen Process). Automatic Pl... | Aug 9, 2013 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.